BNGO Bionano Genomics, Inc. - Common Stock
$1,19
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 10, 2026
52W-Spanne
$1–$6
4% of range
Analystenbewertung
BUY
8 analysts
Kursziel
$5
+320% upside
P/E (TTM)
-0.3
ROE
-58.8%
Nettogewinnmarge
-92.6%
BNGO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.19
Marktkapitalisierung
$13M
P/E (TTM)
-0.3
EPS (TTM)
$-4.85
Umsatz (TTM)
$29M
Dividendenrendite
—
ROE
-58.8%
Verschuldungsgrad
—
52W-Spanne
$1 – $6
BNGO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$29M
2017-12-31
→
2025-12-31
EPS
$-4.85
2021-12-31
→
2025-12-31
Freier Cashflow
—
2018-12-31
→
2020-12-31
Margen
-92.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
BNGO
Peer-Median
P/E (TTM)
-0.3
31.3
P/S (TTM) (K/V (TTM))
0.5
0.5
P/B (K/B)
0.3
1.3
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
BNGO
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-117.0%
—
Net Profit Margin (Nettogewinnmarge)
-92.6%
-11.4%
ROA
-35.1%
-27.7%
ROE
-58.8%
-58.6%
ROIC
-75.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
BNGO
Peer-Median
Current Ratio (Liquiditätsgrad)
2.0
1.7
Quick Ratio
0.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
BNGO
Peer-Median
Revenue YoY (Umsatz YoY)
-7.4%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
0.84%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
27.4%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
BNGO
Peer-Median
BNGO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
8 Analysten
- Starker Kauf 2 25,0%
- Kauf 5 62,5%
- Halten 1 12,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
2 Analysten · 2026-08-16
Median
$5.00
← Unter allen Zielen
$1.19
Tief
$4.00
Hoch
$6.00
Median-Ziel
$5.00
+320,2%
Mittelwert-Ziel
$5.00
+320,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.76%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.64 | $-0.70 | 0.06% |
| 31. März 2026 | $-0.76 | $-0.90 | 0.14% |
| 31. Dezember 2025 | $-0.03 | $-1.43 | 1.4% |
| 30. September 2025 | $-1.59 | $-1.95 | 0.36% |
| 30. Juni 2025 | $-1.99 | $-2.46 | 0.47% |
| 31. März 2025 | $-1.15 | $-3.08 | 1.9% |
| 31. Dezember 2024 | $-15.83 | $-6.12 | -9.7% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BNGO | $16M | -0.3 | -7.4% | -92.6% | -58.8% | — |
| HBIO | $30M | -0.5 | -8.1% | -65.5% | -384.8% | 57.7% |
| CDT | — | — | — | — | — | — |
| BNBX | $6M | -0.0 | 1.1% | -709.5% | -264.9% | 39.3% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $31M | $36M | $28M | $18M | $9M | $10M | $12M | $10M | |
| Cost of Revenue | $15M | $30M | $27M | $22M | $14M | $6M | $7M | $9M | $6M | |
| R&D Expense | $11M | $25M | $54M | $49M | $22M | $10M | $9M | $9M | $12M | |
| SG&A Expense | $35M | $52M | $93M | $89M | $58M | $31M | $20M | $14M | $14M | |
| Operating Expenses | $47M | $104M | $225M | $138M | $81M | $41M | $29M | $24M | $27M | |
| Operating Income | $-33M | $-104M | $-215M | $-132M | $-77M | $-39M | $-26M | $-20M | $-23M | |
| Interest Expense | · | · | $5M | $298.0K | $927.0K | $3M | $2M | $1M | $590.9K | |
| Interest Income | $1M | $2M | $3M | $2M | $400.0K | · | · | · | · | |
| Other Non-op | $6M | $-10M | $-20M | $-223.0K | $-59.0K | $-7.0K | $-4M | $2M | $-128.0K | |
| Pretax Income | $-26M | $-112M | $-232M | $-131M | $-78M | $-41M | $-30M | $-18M | $-23M | |
| Income Tax | $67.0K | $33.0K | $62.0K | $2M | $-6M | $29.0K | $21.0K | $15.5K | $18.6K | |
| Net Income | $-26M | $-112M | $-232M | $-133M | $-72M | $-41M | $-30M | $-18M | $-23M | |
| EPS (Basic) | $-4.85 | $-88.13 | $-408.60 | $-4.58 | $-0.26 | · | · | · | · | |
| EPS (Diluted) | $-4.85 | $-88.13 | $-408.60 | $-4.58 | $-0.26 | · | · | · | · | |
| Shares (Basic) | 5,445,000 | 1,271,000 | 569,000 | 28,921,000 | 276,782,000 | · | · | · | · | |
| Shares (Diluted) | 5,445,000 | 1,271,000 | 569,000 | 28,921,000 | 276,782,000 | · | · | · | · | |
| EBITDA | $-24M | $-90M | $-202M | $-122M | $-74M | $-37M | $-25M | $-19M | · |
Bilanz 27
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $9M | $18M | $5M | $25M | $38M | $17M | $17M | $1M | |
| Receivables | $5M | $5M | $9M | $7M | $5M | $3M | $6M | $5M | $3M | |
| Inventory | $8M | $13M | $28M | $30M | $12M | $3M | $3M | $1M | $2M | |
| Prepaid Expense | $5M | $3M | $6M | $7M | $4M | $2M | $1M | $919.5K | $1M | |
| Other Current Assets | $2M | $1M | $976.0K | $2M | $1M | $462.0K | $457.1K | $384.1K | $550.1K | |
| Current Assets | $45M | $39M | $140M | $157M | $272M | $47M | $28M | $23M | $7M | |
| PP&E (Net) | $15M | $19M | $23M | $18M | $10M | $5M | $2M | $2M | $3M | |
| PP&E (Gross) | $43M | $46M | $42M | $31M | $19M | $12M | $8M | $7M | $7M | |
| Accum. Depreciation | $28M | $27M | $19M | $13M | $9M | $7M | $6M | $5M | $4M | |
| Goodwill | · | · | $0 | $77M | $56M | $7M | $0 | · | · | |
| Intangibles | $4M | $10M | $34M | $41M | $27M | $1M | $0 | · | · | |
| Other Non-current Assets | $3M | $3M | $7M | $2M | $749.0K | $103.0K | $0 | · | · | |
| Total Assets | $74M | $77M | $214M | $308M | $377M | $60M | $30M | $25M | $10M | |
| Accounts Payable | $6M | $7M | $10M | $13M | $11M | $3M | $3M | $1M | $2M | |
| Accrued Liabilities | $5M | $6M | $8M | $11M | $9M | $6M | $3M | $3M | $4M | |
| Current Liabilities | $23M | $37M | $100M | $36M | $22M | $9M | $26M | $5M | $17M | |
| Capital Leases | $2M | $145.0K | $4M | $6M | $5M | $0 | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $0 | $44.5K | $808.4K | $567.0K | |
| Total Liabilities | $29M | $41M | $118M | $58M | $40M | $25M | $27M | $15M | $17M | |
| Long-term Debt | · | · | · | · | · | $16M | $20M | $9M | $7M | |
| Total Debt | · | · | · | · | $0 | $16M | $20M | $9M | · | |
| Common Stock | $1.0K | $0 | $0 | $3.0K | $29.0K | $19.0K | $3.4K | $1.0K | $8 | |
| Retained Earnings | $-720M | $-693M | $-581M | $-349M | $-216M | $-144M | $-103M | $-73M | $-54M | |
| AOCI | $17.0K | $27.0K | $23.0K | $-1M | $-539.0K | $0 | · | · | · | |
| Stockholders' Equity | $44M | $35M | $96M | $249M | $337M | $35M | $4M | $10M | $-50M | |
| Liabilities + Equity | $74M | $77M | $214M | $308M | $377M | $60M | $30M | $25M | $10M | |
| Shares Outstanding | 10,740,200 | 1,865,400 | 762,600 | 495,300 | 28,960,000 | 189,953,000 | 34,274,469 | 10,055,072 | 77,257 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10M | $14M | $14M | $10M | $3M | $1M | $1M | $1M | $2M | |
| Stock-based Comp | $5M | $10M | $15M | $22M | $10M | $2M | $1M | $1M | $382.8K | |
| Deferred Tax | $0 | $0 | $0 | $2M | $-6M | $0 | · | · | · | |
| Amort. of Intangibles | $5M | $7M | $7M | $6M | $1M | $100.0K | · | · | · | |
| Restructuring | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-4M | $19M | $78M | $-26M | $-7M | $-241.6K | $-2M | $-4M | · | |
| Operating Cash Flow | $-16M | $-69M | $-125M | $-125M | $-72M | $-38M | $-30M | $-20M | $-21M | |
| CapEx | · | · | · | · | · | $0 | $61.1K | $331.7K | $1M | |
| Investing Cash Flow | $-13M | $74M | $24M | $83M | $-278M | $-2M | $-61.1K | $-331.7K | $-1M | |
| Stock Issued | $31M | $44M | $58M | $23M | · | · | · | · | · | |
| Net Stock Activity | $31M | $44M | $58M | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $-14M | $114M | $23M | $336M | $62M | $30M | $36M | $18M | |
| Net Change in Cash | $-5M | $-9M | $13M | $-19M | $-14M | $21M | $788.6K | $16M | $-4M | |
| Taxes Paid | $119.0K | $54.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-38M | $-30M | $-20M | · | |
| Levered FCF | · | · | · | · | · | $-41M | $-32M | $-22M | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -117.0% | -337.9% | -596.0% | -473.7% | -428.8% | -453.4% | -255.4% | -170.1% | · | |
| Net Margin | -92.6% | -364.0% | -643.7% | -476.9% | -402.8% | -483.4% | -294.3% | -154.1% | · | |
| Pretax Margin | -92.3% | -363.9% | -643.6% | -470.2% | -434.6% | -483.1% | -294.1% | -154.0% | · | |
| EBITDA Margin | -83.5% | -292.3% | -558.0% | -439.1% | -410.2% | -436.0% | -244.3% | -159.1% | · | |
| ROA | -35.1% | -77.0% | -89.1% | -38.7% | -33.1% | -90.7% | -108.4% | -105.8% | · | |
| ROE | -58.8% | -265.9% | -216.1% | -49.9% | -21.3% | -165.2% | 1583.7% | -145.8% | · | |
| ROIC | -75.2% | -294.0% | -223.9% | -53.6% | -21.2% | -75.0% | -109.3% | -106.6% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.1 | 1.4 | 4.4 | 12.5 | 5.2 | 1.1 | 5.1 | · | |
| Quick Ratio | 0.4 | 0.4 | 0.3 | 0.3 | 1.4 | 4.6 | 0.9 | 4.7 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.5 | 5.6 | 0.9 | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | 0.5 | 0.0 | 0.9 | · | |
| Interest Coverage | · | · | -42.0 | -441.9 | -83.2 | -15.3 | -11.3 | -14.8 | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.7 | · | |
| Inventory Turnover | 1.5 | 1.5 | 0.9 | 1.0 | 1.8 | 1.7 | 3.0 | 6.3 | · | |
| Receivables Turnover | 5.7 | 4.4 | 4.4 | 4.7 | 4.7 | 1.9 | 1.9 | 3.1 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -7.4% | -14.8% | 29.9% | 54.6% | 111.5% | · | · | · | · | |
| Revenue CAGR 3Y | 0.84% | 19.6% | 62.0% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.4% | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $29M | $31M | $36M | $28M | $18M | $9M | $10M | $12M | · | |
| Net Income TTM | $-26M | $-112M | $-232M | $-133M | $-72M | $-41M | $-30M | $-18M | · | |
| Market Cap | $16M | $32M | $5.19B | $260.33B | $519.55B | $351.03B | $25.50B | $31.61B | · | |
| Enterprise Value | · | · | · | · | $519.52B | $351.01B | $25.50B | $31.61B | · | |
| P/E | -0.3 | -0.2 | -0.3 | -191.3 | -6900.0 | · | · | · | · | |
| P/S | 0.6 | 1.1 | 143.7 | 9363.8 | 28894.2 | 41283.4 | 2517.4 | 2634.3 | · | |
| P/B | 0.4 | 0.9 | 54.0 | 1043.8 | 1541.1 | 10006.0 | 7056.5 | 3118.5 | · | |
| P / Tangible Book | 0.4 | 1.3 | 83.4 | 1987.8 | 2044.5 | 13279.6 | · | · | · | |
| P / Cash Flow | -1.0 | -0.5 | -41.4 | -2085.7 | -7223.2 | -9161.9 | -863.5 | -1585.1 | · | |
| P / FCF | · | · | · | · | · | -9161.9 | -861.8 | -1559.2 | · | |
| EV / EBITDA | · | · | · | · | -7044.4 | -9468.4 | -1030.5 | -1655.2 | · | |
| EV / FCF | · | · | · | · | · | -9161.3 | -861.9 | -1558.8 | · | |
| EV / Revenue | · | · | · | · | 28892.8 | 41280.8 | 2517.7 | 2633.6 | · | |
| Earnings Yield | -317.0% | -506.5% | -360.3% | -0.52% | -0.01% | · | · | · | · |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $7M | $8M | $7M | $7M | $6M | $8M | $6M | $8M | $9M | $11M | $9M | $9M | $7M | $8M | $7M | |
| Cost of Revenue | $4M | $3M | $5M | $4M | $3M | $4M | $5M | $15M | $5M | $6M | $8M | $7M | $6M | $5M | $6M | $5M | |
| R&D Expense | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $5M | $7M | $10M | $12M | $14M | $15M | $14M | $14M | $13M | |
| SG&A Expense | $9M | $8M | $9M | $9M | $8M | $9M | $12M | $9M | $12M | $19M | $15M | $25M | $27M | $26M | $25M | $21M | |
| Operating Expenses | $12M | $11M | $12M | $12M | $11M | $11M | $15M | $35M | $20M | $34M | $27M | $116M | $42M | $40M | $39M | $34M | |
| Operating Income | $-7M | $-8M | $-9M | $-9M | $-8M | $-8M | $-12M | $-44M | $-17M | $-31M | $-25M | $-113M | $-39M | $-38M | $-38M | $-32M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $122.0K | · | $71.0K | $74.0K | $76.0K | $74.0K | $73.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $800.0K | $400.0K | |
| Other Non-op | $-344.0K | $-619.0K | $363.0K | $-219.0K | $676.0K | $5M | $-8M | $-697.0K | $363.0K | $-1M | $-20M | $-45.0K | $-330.0K | $117.0K | $-39.0K | $5.0K | |
| Pretax Income | $-7M | $-8M | $-8M | $-8M | $-7M | $-3M | $-20M | $-44M | $-16M | $-31M | $-44M | $-113M | $-39M | $-37M | $-37M | $-32M | |
| Income Tax | $7.0K | $10.0K | $36.0K | $14.0K | $10.0K | $7.0K | $1.0K | $24.0K | $26.0K | $-18.0K | $-36.0K | $39.0K | $33.0K | $26.0K | $2M | $28.0K | |
| Net Income | $-7M | $-8M | $-8M | $-9M | $-7M | $-3M | $-20M | $-44M | $-16M | $-31M | $-44M | $-113M | $-39M | $-37M | $-39M | $-32M | |
| EPS (Basic) | $-0.64 | $-0.76 | $-0.12 | $-1.59 | $-1.99 | $-1.15 | $-7.05 | $-30.92 | $-14.41 | $-35.75 | $-402.91 | $-3.22 | $-1.24 | $-1.23 | $-2.24 | $-1.10 | |
| EPS (Diluted) | $-0.64 | $-0.76 | $-0.12 | $-1.59 | $-1.99 | $-1.15 | $-7.05 | $-30.92 | $-14.41 | $-35.75 | $-402.91 | $-3.22 | $-1.24 | $-1.23 | $-2.24 | $-1.10 | |
| Shares (Basic) | 11,546,000 | 10,979,000 | -6,028,000 | 5,338,000 | 3,441,000 | 2,694,000 | -2,165,000 | 1,431,000 | 1,126,000 | 879,000 | -96,135,000 | 35,001,000 | 31,498,000 | 30,205,000 | -313,217,000 | 28,970,000 | |
| Shares (Diluted) | 11,546,000 | 10,979,000 | -6,028,000 | 5,338,000 | 3,441,000 | 2,694,000 | -2,165,000 | 1,431,000 | 1,126,000 | 879,000 | -96,135,000 | 35,001,000 | 31,498,000 | 30,205,000 | -313,217,000 | 28,970,000 | |
| EBITDA | $-7M | $-6M | · | $-9M | $-8M | $-6M | · | $-44M | $-17M | $-28M | · | $-113M | $-39M | $-35M | · | $-32M |
Bilanz 24
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $3M | $3M | $4M | $4M | $9M | $9M | $10M | $16M | $18M | $35M | $15M | $4M | $5M | $28M | |
| Receivables | $4M | $4M | $5M | $5M | $3M | $3M | $5M | $5M | $6M | $8M | $9M | $9M | $8M | $7M | $7M | $6M | |
| Inventory | $7M | $8M | $8M | $8M | $10M | $11M | $13M | $16M | $23M | $24M | $28M | $34M | $32M | $33M | $30M | $25M | |
| Prepaid Expense | $5M | $5M | $5M | $5M | $3M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $5M | $7M | $7M | $7M | |
| Other Current Assets | · | · | $2M | · | · | · | $1M | · | · | · | $976.0K | · | · | · | $2M | · | |
| Current Assets | $25M | $39M | $45M | $49M | $43M | $45M | $39M | $47M | $61M | $86M | $140M | $105M | $123M | $143M | $157M | $218M | |
| PP&E (Net) | $13M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $25M | $25M | $23M | $21M | $20M | $19M | $18M | $16M | |
| PP&E (Gross) | $42M | $43M | $43M | · | · | · | $46M | · | · | · | $42M | · | · | · | $31M | · | |
| Accum. Depreciation | $29M | $29M | $28M | · | · | · | $27M | · | · | · | $19M | · | · | · | $13M | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $77M | $77M | $77M | $56M | |
| Intangibles | $2M | $3M | $4M | $6M | $7M | $8M | $10M | $11M | $30M | $32M | $34M | $36M | $38M | $39M | $41M | $23M | |
| Other Non-current Assets | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $6M | $7M | $7M | $10M | $3M | $3M | $2M | $802.0K | |
| Total Assets | $48M | $65M | $74M | $79M | $76M | $78M | $77M | $87M | $129M | $158M | $214M | $182M | $271M | $292M | $308M | $324M | |
| Accounts Payable | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $9M | $9M | $10M | $10M | $15M | $12M | $16M | $13M | $9M | |
| Accrued Liabilities | $3M | $4M | $5M | $5M | $3M | $4M | $6M | $6M | $6M | $11M | $8M | $12M | $8M | $9M | $11M | $12M | |
| Current Liabilities | $10M | $21M | $23M | $23M | $24M | $26M | $37M | $33M | $37M | $59M | $100M | $40M | $33M | $38M | $36M | $34M | |
| Capital Leases | $2M | $3M | $2M | $3M | $3M | $0 | $145.0K | $2M | $2M | $3M | $4M | $4M | $5M | $5M | $6M | $5M | |
| Total Liabilities | $16M | $27M | $29M | $29M | $31M | $30M | $41M | $38M | $49M | $75M | $118M | $63M | $57M | $61M | $58M | $42M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $9.0K | $7.0K | $6.0K | $0 | $3.0K | $3.0K | $31.0K | $3.0K | $30.0K | |
| Retained Earnings | $-735M | $-728M | $-720M | $-712M | $-703M | $-696M | $-693M | $-673M | $-629M | $-613M | $-581M | $-537M | $-425M | $-386M | $-349M | $-310M | |
| AOCI | $14.0K | $12.0K | $17.0K | $6.0K | $-10.0K | $14.0K | $27.0K | $2M | $-3.0K | $-16.0K | $23.0K | $-93.0K | $-310.0K | $-665.0K | $-1M | $-2M | |
| Stockholders' Equity | $32M | $37M | $44M | $50M | $45M | $48M | $35M | $49M | $80M | $83M | $96M | $119M | $215M | $231M | $249M | $282M | |
| Liabilities + Equity | $48M | $65M | $74M | $79M | $76M | $78M | $77M | $87M | $129M | $158M | $214M | $182M | $271M | $292M | $308M | $324M | |
| Shares Outstanding | 11,777,300 | 11,276,500 | 10,740,200 | 9,730,400 | 3,909,400 | 3,101,400 | 1,865,400 | 88,468,000 | 70,776,000 | 57,539,000 | 762,533 | 35,349,000 | 33,240,000 | 306,790,000 | 29,718,000 | 296,900,000 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $6M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $970.0K | $670.0K | $926.0K | $941.0K | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $6M | |
| Other Non-cash | · | $-393.0K | · | · | · | $-4M | · | · | · | $-3M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-5M | $-6M | $-4M | $-6M | $-3M | $-3M | $-7M | $-13M | $-21M | $-28M | $-30M | $-26M | $-37M | $-32M | $-35M | $-29M | |
| Investing Cash Flow | $14M | $5M | $4M | $-5M | $2M | $-14M | $3M | $-5M | $29M | $48M | $-55M | $33M | $30M | $17M | $12M | $8M | |
| Stock Issued | $620.0K | $705.0K | $2M | $13M | $3M | $13M | $7M | $10M | $12M | $15M | $11M | $13M | $18M | $15M | $0 | $23M | |
| Net Stock Activity | · | $705.0K | · | · | · | $13M | · | · | · | $15M | · | · | · | $15M | · | · | |
| Financing Cash Flow | $-10M | $657.0K | $2M | $10M | $1M | $11M | $4M | $6M | $-2M | $-22M | $68M | $13M | $18M | $15M | $146.0K | $23M | |
| Net Change in Cash | $-681.0K | $403.0K | $1M | $-497.0K | $-63.0K | $-6M | $379.0K | $-13M | $6M | $-2M | $-17M | $20M | $11M | $-987.0K | $-23M | $1M |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -88.3% | -118.1% | · | -115.9% | -115.9% | -131.1% | · | -722.9% | -219.0% | -354.9% | · | -1215.0% | -453.0% | -510.4% | · | -445.2% | |
| Net Margin | -90.8% | -124.2% | · | -115.4% | -101.8% | -48.0% | · | -728.6% | -208.8% | -358.3% | · | -1208.1% | -449.2% | -500.7% | · | -440.5% | |
| Pretax Margin | -90.8% | -124.0% | · | -115.2% | -101.7% | -47.9% | · | -728.2% | -208.4% | -358.5% | · | -1207.6% | -448.9% | -500.3% | · | -440.1% | |
| EBITDA Margin | -88.3% | -83.5% | · | -115.9% | -115.9% | -93.4% | · | -722.9% | -219.0% | -320.6% | · | -1215.0% | -453.0% | -467.3% | · | -445.2% | |
| ROA | -12.0% | -11.6% | · | -10.2% | -6.7% | -2.6% | · | -32.9% | -8.1% | -14.0% | · | -44.5% | -13.1% | -11.6% | · | -9.3% | |
| ROE | -19.3% | -19.4% | · | -17.2% | -10.9% | -4.7% | · | -52.7% | -11.0% | -20.0% | · | -56.2% | -15.6% | -13.7% | · | -10.2% | |
| ROIC | -22.9% | -21.1% | · | -17.2% | -17.2% | -17.6% | · | -89.9% | -21.2% | -37.6% | · | -95.2% | -18.3% | -16.4% | · | -11.4% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 1.8 | · | 2.1 | 1.8 | 1.7 | · | 1.4 | 1.6 | 1.5 | · | 2.6 | 3.7 | 3.7 | · | 6.5 | |
| Quick Ratio | 0.8 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 1.1 | 0.7 | 0.3 | · | 1.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -255.1 | · | -1594.5 | -530.2 | -497.9 | · | -440.4 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.3 | 0.2 | 0.2 | · | 0.6 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Receivables Turnover | 2.1 | 1.8 | · | 1.5 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 1.3 | 1.4 | 1.2 | · | 1.6 |
Bewertung (TTM) 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $29M | $27M | · | $27M | $27M | $29M | · | $32M | $35M | $34M | · | $33M | $30M | $27M | · | $24M | |
| Net Income TTM | $-31M | $-27M | · | $-63M | $-70M | $-95M | · | $-204M | $-199M | $-220M | · | $-220M | $-140M | $-131M | · | $-115M | |
| Market Cap | $13M | $13M | · | $17M | $13M | $9M | · | $2.39B | $2.89B | $3.83B | · | $6.43B | $12.17B | $204.32B | · | $326.00B | |
| P/E | -0.2 | -0.2 | · | -0.0 | -0.1 | -0.0 | · | -0.3 | -0.7 | -1.6 | · | -26.8 | -77.9 | -186.6 | · | -455.6 | |
| P/S | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.3 | · | 74.8 | 83.7 | 112.2 | · | 197.0 | 406.0 | 7566.9 | · | 13447.6 | |
| P/B | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 48.9 | 35.9 | 46.3 | · | 54.0 | 56.6 | 882.7 | · | 1157.1 | |
| P / Tangible Book | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | · | 63.2 | 57.4 | 75.1 | · | 77.2 | 121.8 | 1779.1 | · | 1608.3 | |
| P / Cash Flow | · | -2.3 | · | · | · | -3.1 | · | · | · | -136.2 | · | · | · | -6303.7 | · | · | |
| Earnings Yield | -440.7% | -469.2% | · | -2084.8% | -1477.7% | -2947.3% | · | -312.2% | -133.9% | -62.2% | · | -3.7% | -1.3% | -0.54% | · | -0.22% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $29M | $31M | $36M | $28M | $18M |
| Betriebsgewinnmarge % | -117.0% | -337.9% | -596.0% | -473.7% | -428.8% |
| Nettoergebnis | $-26M | $-112M | $-232M | $-133M | $-72M |
| Verwässerte EPS | $-4.85 | $-88.13 | $-408.60 | $-4.58 | $-0.26 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | — | — | 0.0 |
| Liquiditätsgrad | 2.0 | 1.1 | 1.4 | 4.4 | 12.5 |
| Quick Ratio | 0.4 | 0.4 | 0.3 | 0.3 | 1.4 |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 36 Einreicher · $661K gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 11 (+4 vs. Vorquartal) | 6 (-1 vs. Vorquartal) | 10 (+2 vs. Vorquartal) | 2 (-2 vs. Vorquartal) | -59K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| CARRET ASSET MANAGEMENT, LLC | $141.250 | 125.000 | 21,38% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $93.098 | 82.388 | 14,09% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $79.987 | 70.784 | 12,11% | Aktien |
| VANGUARD GROUP INC | $78.914 | 51.578 | 11,95% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $58.283 | 51.578 | 8,82% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $57.743 | 51.100 | 8,74% | Aktien |
| PRUDENTIAL FINANCIAL INC | $35.708 | 31.600 | 5,41% | Aktien |
| NORTHERN TRUST CORP | $27.754 | 24.561 | 4,20% | Aktien |
| JANE STREET GROUP, LLC | $25.085 | 22.199 | 3,80% | Aktien |
| XTX Topco Ltd | $18.413 | 16.295 | 2,79% | Aktien |
| Engineers Gate Manager LP | $13.546 | 11.988 | 2,05% | Aktien |
| BlackRock, Inc. | $11.228 | 9.936 | 1,70% | Aktien |
| OSAIC HOLDINGS, INC. | $8.766 | 7.762 | 1,33% | Aktien |
| Tower Research Capital LLC (TRC) | $5.908 | 5.228 | 0,89% | Aktien |
| MORGAN STANLEY | $1.170 | 1.035 | 0,18% | Aktien |
| Concord Wealth Partners | $1.130 | 1.000 | 0,17% | Aktien |
| GROUP ONE TRADING LLC | $1.081 | 957 | 0,16% | Aktien |
| UBS Group AG | $918 | 812 | 0,14% | Aktien |
| SBI Securities Co., Ltd. | $278 | 246 | 0,04% | Aktien |
| GSA CAPITAL PARTNERS LLP | $170 | 150.284 | 0,03% | Aktien |
| WELLS FARGO & COMPANY/MN | $128 | 113 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $15 | 13 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $13 | 11 | 0,00% | Aktien |
| HRT FINANCIAL LP | $13 | 11.740 | 0,00% | Aktien |
| TD Waterhouse Canada Inc. | $6 | 5 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $6 | 5 | 0,00% | Aktien |
| AllSquare Wealth Management LLC | $5 | 3 | 0,00% | Aktien |
| BARCLAYS PLC | $3 | 3 | 0,00% | Aktien |
| Activest Wealth Management | $3 | 3 | 0,00% | Aktien |
| CITIGROUP INC | $3 | 3 | 0,00% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $2 | 2 | 0,00% | Aktien |
| Rockefeller Capital Management L.P. | $1 | 1 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $1 | 1 | 0,00% | Aktien |
| Atlantic Union Bankshares Corp | $1 | 1 | 0,00% | Aktien |
| Medallion Wealth Advisors, LLC | $1 | 1 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $0 | 10 | 0,00% | Aktien |
Unternehmensinsider 26 Insider · 10 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Erik R. Holmlin | President and CEO | 15. Februar 2023 A | 841.615 | 0 | 0 | $0 |
| Gulsen Kama | Chief Financial Officer | 18. September 2023 A | — | 0 | 0 | $0 |
| Christopher P. Stewart | Chief Financial Officer | 15. Februar 2023 A | 231.373 | 0 | 0 | $0 |
| Michael James Ward | Former Chief Financial Officer | 1. März 2019 A | — | 0 | 0 | $0 |
| Soheil Shams | Chief Informatics Officer | 15. Februar 2022 A | 5.325.378 | 0 | 0 | $0 |
| Richard Shippy | Chief Business Officer | 15. Februar 2022 A | — | 0 | 0 | $0 |
| Robert J Priar | Chief Commercial Officer | 1. Juni 2021 A | — | 0 | 0 | $0 |
| Heather Adams | Chief Administrative Officer | 18. Februar 2020 A | — | 0 | 0 | $0 |
| Warren Robinson | Chief Commercial Officer | 1. März 2019 A | — | 0 | 0 | $0 |
| Han Cao PHD | Chief Scientific Officer | 1. Oktober 2018 A | 112.936 | 0 | 0 | $0 |
| David L Barker | Direktor | 14. Mai 2026 A | 13.894 | 0 | 0 | $0 |
| Aleksandar Rajkovic | Direktor | 9. Juni 2022 A | — | 0 | 0 | $0 |
| Vincent Jung-Fai Wong | Direktor | 9. Juni 2022 A | — | 0 | 0 | $0 |
| Yvonne Linney | Direktor | 30. Juni 2020 A | — | 0 | 0 | $0 |
| Hannah Mamuszka | Direktor | 30. Juni 2020 A | — | 0 | 0 | $0 |
| Albert Luderer | Direktor | 30. Juni 2020 A | — | 0 | 0 | $0 |
| Kristiina Vuori MD | Direktor | 30. Juni 2020 A | — | 0 | 0 | $0 |
| Junfeng Wang | Direktor | 6. Juni 2019 A | 2.906.915 | 0 | 0 | $0 |
| Quan Zhou | Direktor | 6. Juni 2019 A | 2.906.915 | 0 | 0 | $0 |
| Darren Cai | Direktor | 6. Juni 2019 A | — | 0 | 0 | $0 |
| Alex Reid Hastie | — | 3. August 2026 A | — | 0 | 0 | $0 |
| Mark Adamchak | — | 3. August 2026 A | 253 | 0 | 0 | $0 |
| Jonathan V. Dixon | — | 3. August 2026 A | 239 | 0 | 0 | $0 |
| Mark Borodkin | — | 3. August 2026 A | 868 | 0 | 0 | $0 |
| Alka Chaubey | — | 3. Juni 2026 F | 620 | 0 | 0 | $0 |
| Christopher J Twomey | — | 14. Mai 2026 A | 64.500 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Innovatus Life Sciences GP, LP, Innovatus Life Sciences Lending Fund I, LP, Innovatus Capital Partners, LLC, Innovatus Life Sciences Offshore GP, LP, Innovatus Life Sciences Offshore Fund I-A, LP ×3 Einreichungen | 13. November 2019 | — | Erste Einreichung | — | SEC |
| LC Fund VI, L.P. (2), LC Parallel Fund VI, L.P. (2), LC Healthcare Fund I, L.P. (2), Rosy Shine Limited (2), Legend Holdings (2), Legend Capital (2), Junfeng Wang (2), Quan Zhou (2), Linan Zhu (2), Hao Chen (2), Nengguang Wang (2) | 7. Juni 2019 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 1 ETF
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 82.388 SH | 8. August 2026 | Täglich |